DE60116662D1 - Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen - Google Patents

Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Info

Publication number: DE60116662D1
Authority: DE; Germany
Prior art keywords: inhibition; systemic infections; dietary fiber; ballasts; swiveling
Prior art date: 2000-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60116662T

Other languages

English (en)

Other versions

DE60116662T2 (de

Inventor

K Buddington

Loo Jan Van

Anne Frippiat

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Tiense Suikerraffinaderij NV

Mississippi State University

Original Assignee

Tiense Suikerraffinaderij NV

Mississippi State University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-28

Filing date

2001-09-27

Publication date

2006-04-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60116662(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-27 Application filed by Tiense Suikerraffinaderij NV, Mississippi State University filed Critical Tiense Suikerraffinaderij NV

2006-04-06 Application granted granted Critical

2006-04-06 Publication of DE60116662D1 publication Critical patent/DE60116662D1/de

2006-11-09 Publication of DE60116662T2 publication Critical patent/DE60116662T2/de

2021-09-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

208000015181 infectious disease Diseases 0.000 title abstract 3
230000005764 inhibitory process Effects 0.000 title abstract 3
230000009885 systemic effect Effects 0.000 title abstract 3
235000013325 dietary fiber Nutrition 0.000 abstract 5
239000000203 mixture Substances 0.000 abstract 4
229920001202 Inulin Polymers 0.000 abstract 2
241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
244000052616 bacterial pathogen Species 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
241000723343 Cichorium Species 0.000 abstract 1
235000007542 Cichorium intybus Nutrition 0.000 abstract 1
229920002670 Fructan Polymers 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000006116 polymerization reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

DE60116662T 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen Expired - Lifetime DE60116662T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US671106		2000-09-28
US09/671,106 US7431939B1 (en)	2000-09-28	2000-09-28	Inhibition of systemic infections in humans and vertebrates by dietary fibers
PCT/EP2001/011198 WO2002026242A2 (en)	2000-09-28	2001-09-27	Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (2)

Publication Number	Publication Date
DE60116662D1 true DE60116662D1 (de)	2006-04-06
DE60116662T2 DE60116662T2 (de)	2006-11-09

Family

ID=24693153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60116662T Expired - Lifetime DE60116662T2 (de)	2000-09-28	2001-09-27	Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Country Status (11)

Country	Link
US (1)	US7431939B1 (de)
EP (1)	EP1320375B1 (de)
JP (1)	JP4309650B2 (de)
CN (1)	CN1315482C (de)
AT (1)	ATE315399T1 (de)
CA (1)	CA2423783C (de)
DE (1)	DE60116662T2 (de)
DK (1)	DK1320375T3 (de)
ES (1)	ES2252317T3 (de)
NO (1)	NO331751B1 (de)
WO (1)	WO2002026242A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) *	2002-06-26	2004-01-01	Armand Malnoe	Compositions and methods for detoxification and cancer prevention
DE602006008985D1 (de)	2005-12-16	2009-10-15	Nutricia Nv	Zusammensetzung enthaltend oligosaccharide als lösliche ballaststoffe zur verwendung gegen muskelschwund
AU2007245002B2 (en) *	2006-03-29	2012-05-03	Société des Produits Nestlé S.A.	Dietary supplements containing probiotics
US20090061008A1 (en) *	2007-08-30	2009-03-05	Levy Mark M	Fiber/granule complex for treatment of the gi tract
US20110117077A1 (en)	2008-06-13	2011-05-19	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section
EP2588071B1 (de) *	2010-06-30	2019-05-22	Nestec S.A.	Verwendung von cichoriensäure und derivate zum aufhellen und / oder bleichen der hautfarbe
ES2738632T3 (es)	2012-02-16	2020-01-24	Akeso Biomedical Inc	Complejos de hierro para la reducción de la colonización del tracto gastrointestinal por Campylobacter
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
CA2957790A1 (en) *	2014-08-13	2016-02-18	Akeso Biomedical, Inc.	Antimicrobial compounds and compositions, and uses thereof
CN104872457A (zh) *	2015-06-23	2015-09-02	通威股份有限公司	一种提高罗非鱼抗链球菌能力的配合饲料
MX2017016466A (es) *	2015-06-23	2018-05-17	Nestec Sa	Composiciones nutritivas y formulas infantiles que contienen oligofructosa para reducir la carga de bacterias patogenas en el intestino de infantes y niños pequeños.
WO2017021413A1 (en) *	2015-08-04	2017-02-09	Südzucker AG	Prophylactic use of inulin against sinusitis
WO2017027742A1 (en)	2015-08-11	2017-02-16	Akeso Biomedical, Inc.	Biofilm inhibiting compositions enhancing weight gain in livestock
US10653658B2 (en)	2015-08-11	2020-05-19	Akeso Biomedical, Inc.	Biofilm inhibiting compositions enhancing weight gain in livestock
CN105124248A (zh) *	2015-08-28	2015-12-09	通威股份有限公司	一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (de) *	2016-02-17	2017-08-23	Proponent Biotech GmbH	Verwendungen von polyfructanen
BE1025705B1 (fr) *	2017-09-12	2019-06-18	Cosucra Groupe Warcoing Sa	Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) *	2018-02-28	2020-11-24	The Trustees Of Columbia University In The City Of New York	Inulin for preventing antibiotic resistant infection and pathogen colonization

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4954622A (en) *	1985-10-31	1990-09-04	The Australian National University	Pharmaceutical composition and method containing gamma inulin or derivative thereof
US5032579A (en)	1987-10-13	1991-07-16	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
DK0483070T3 (da)	1990-10-24	1995-07-17	Sandoz Nutrition Ltd	Næringsmæssigt komplet fødevaresammensætning indeholdende hydrolyseret opløselig fiber
ES2060543B1 (es) *	1993-03-26	1995-04-01	Cia Gral Del Algarrobo De Espa	Fibra natural de algarroba y procedimiento para su obtencion.
DK0638589T3 (da)	1993-08-10	1998-09-21	Suedzucker Ag	Inulinderivater, fremgangsmåde til deres fremstilling og deres anvendelse
EP1362587A1 (de)	1994-01-11	2003-11-19	Stichting Zofia	Verwendung von Glutamin zur Behandlung von niedrigen Arginin Plasmaspiegel des menschlichen oder tierischen Körpers
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
US6241983B1 (en) *	1994-10-28	2001-06-05	Metagenics, Inc.	Bacteria-and fiber-containing composition for human gastrointestinal health
ES2123903T5 (es) *	1995-08-04	2011-02-22	N.V. Nutricia	Composición nutritiva conteniendo fibra.
EP0879600A1 (de) *	1997-05-20	1998-11-25	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
ES2221014T3 (es)	1997-06-23	2004-12-16	Societe Des Produits Nestle S.A.	Composicion nutritiva que contiene fibras de guisante e inulina.
EP0904784A1 (de)	1997-09-22	1999-03-31	N.V. Nutricia	Probiotisches Ernährungspräparat
US6248375B1 (en) *	2000-03-14	2001-06-19	Abbott Laboratories	Diabetic nutritionals and method of using
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (de)	2002-09-27	2004-06-16	Tiense Suikerraffinaderij N.V.	Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs

2000
- 2000-09-28 US US09/671,106 patent/US7431939B1/en not_active Expired - Lifetime
2001
- 2001-09-27 CN CNB018165524A patent/CN1315482C/zh not_active Expired - Fee Related
- 2001-09-27 ES ES01985674T patent/ES2252317T3/es not_active Expired - Lifetime
- 2001-09-27 DK DK01985674T patent/DK1320375T3/da active
- 2001-09-27 DE DE60116662T patent/DE60116662T2/de not_active Expired - Lifetime
- 2001-09-27 EP EP01985674A patent/EP1320375B1/de not_active Revoked
- 2001-09-27 AT AT01985674T patent/ATE315399T1/de not_active IP Right Cessation
- 2001-09-27 CA CA002423783A patent/CA2423783C/en not_active Expired - Fee Related
- 2001-09-27 JP JP2002530072A patent/JP4309650B2/ja not_active Expired - Fee Related
- 2001-09-27 WO PCT/EP2001/011198 patent/WO2002026242A2/en active IP Right Grant
2003
- 2003-03-19 NO NO20031259A patent/NO331751B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2423783C (en)	2007-11-20
CN1315482C (zh)	2007-05-16
US7431939B1 (en)	2008-10-07
DE60116662T2 (de)	2006-11-09
JP2004509922A (ja)	2004-04-02
NO331751B1 (no)	2012-03-19
EP1320375B1 (de)	2006-01-11
NO20031259L (no)	2003-05-07
JP4309650B2 (ja)	2009-08-05
NO20031259D0 (no)	2003-03-19
CA2423783A1 (en)	2002-04-04
WO2002026242A2 (en)	2002-04-04
DK1320375T3 (da)	2006-05-22
ATE315399T1 (de)	2006-02-15
EP1320375A2 (de)	2003-06-25
ES2252317T3 (es)	2006-05-16
WO2002026242A3 (en)	2002-05-30
CN1466460A (zh)	2004-01-07

Legal Events

Date	Code	Title	Description
2007-01-04	8363	Opposition against the patent

Publication	Publication Date	Title
DE60116662D1 (de)	2006-04-06	Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
BR9706897A (pt)	1999-08-31	Composições antifúngicas com biodisponibilidade aperfeiçoada.
RO116342B1 (ro)	2001-01-30	Compoziţie farmaceutică lichidă, orală
NO304638B1 (no)	1999-01-25	Peroralt anvendelige legemiddelformer for behandling av sentrale dopaminmangeltilstander
BG101781A (en)	1998-03-31	Active substance-containing solid preparation
BG103862A (en)	2000-07-31	Compositions of derivatives of erythromycin with continuous release
AR098808A2 (es)	2016-06-15	Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos
HUP0003323A2 (hu)	2001-06-28	Vorikonazolt tartalmazó gyógyászati készítmények
CY1105908T1 (el)	2011-02-02	Στοματικως αποσαθρουμενα δισκια που πepιλαμβανουν βενζιμιδαζολιο
HUP9802356A2 (hu)	2000-06-28	Foggondozó táplálék hobbi állatoknak
BG101118A (en)	1998-04-30	Therapeutical compounds
SE9800550D0 (sv)	1998-02-24	A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
KR970706815A (ko)	1997-12-01	온단세트론을 포함하는 경구 조성물(Oral Compositions Containing Ondansetron)
TR200100629T2 (tr)	2001-07-23	Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
JP2004509922A5 (de)	2005-04-28
DE60109202D1 (de)	2005-04-07	Pharmazeutische aerosolformulierung
MXPA02009064A (es)	2004-08-12	Pelicula superabsorbente a base de polisacarido..
FI955837A0 (fi)	1995-12-04	Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
DE69126183D1 (de)	1997-06-26	LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente
GEP20043254B (en)	2004-06-25	Use of Camptothecin Derivatives with Reduced Gastrointestinal Toxicity
KR910016327A (ko)	1991-11-05	호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR960003718A (ko)	1996-02-23	말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
RU93016671A (ru)	1995-05-10	Иммуномодулятор
AU2001295839A1 (en)	2002-05-15	Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa
PT1337260E (pt)	2005-05-31	Preparacao para fortalecimento da resposta imunologica no anel de waldeyer e mucosa buconasal por administracao intranasal